Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
213.60    0.60 (0.28%)
Bid:
213.40
Ask:
213.80
Spread: 0.40 (0.187%)
Market Cap: £4.17b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Holding(s) in Company

9 Jun 2017 11:41

RNS Number : 6811H
ConvaTec Group PLC
09 June 2017
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CONVATEC GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

ACP CONVATEC, LLC

 

4. Full name of shareholder(s) (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

8 JUNE 2017

 

6. Date on which issuer notified:

9 JUNE 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 3%

     
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY SHARES OF £0.10 EACH

137,244,619

137,244,619

58,244,619

58,244,619

N/A

2.98%

N/A

GB00BD3VFW73

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

58,244,619

2.98%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

N/A

 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

This disclosure has been calculated based on an issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its AGM results announcement dated 11 May 2017.

14. Contact name:

BEN SILBERT, CHIEF ADMINISTRATIVE OFFICER & GENERAL COUNSEL

 

15. Contact telephone number:

+1 212 593 6958

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEKNELEXEFF
Date   Source Headline
5th Mar 20217:00 amRNSAnnual Results
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration
30th Nov 20203:45 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:30 pmRNSTotal Voting Rights
30th Oct 202010:40 amRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
20th Oct 20204:05 pmRNSDirector/PDMR Shareholding
19th Oct 20203:30 pmRNSDirector/PDMR Shareholding
12th Oct 20202:00 pmRNSHolding(s) in Company
7th Oct 202011:50 amRNSDirector Declaration
5th Oct 20206:35 pmRNSHolding(s) in Company
29th Sep 20202:05 pmRNSScrip Dividend - Total Issued Shares
10th Sep 20201:00 pmRNSScrip Dividend - Calculation Price
28th Aug 20203:54 pmRNSDirector/PDMR Shareholding
28th Aug 20203:42 pmRNSDirector/PDMR Shareholding
11th Aug 20209:40 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSInterim Results
13th Jul 202011:00 amRNSNon-Executive Director appointment
30th Jun 20207:00 amRNSBoard Committee Changes
10th Jun 202010:00 amRNSHolding(s) in Company
1st Jun 202010:45 amRNSTotal Voting Rights
29th May 202010:00 amRNSBoard Change
19th May 202010:40 amRNSDirector/PDMR Shareholding
19th May 202010:35 amRNSDirector/PDMR Shareholding
18th May 20204:30 pmRNSHolding(s) in Company
14th May 202010:45 amRNSHolding(s) in Company
11th May 20204:10 pmRNSNon-Executive Director appointment
7th May 20204:15 pmRNSResult of AGM
5th May 20202:15 pmRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSConvaTec Group Plc Q1 2020 Trading Update
28th Apr 20202:20 pmRNSScrip Dividend - Total Issued Shares
22nd Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202012:30 pmRNSScrip Dividend - Calculation Price
3rd Apr 202011:00 amRNSDirector Declaration
2nd Apr 202012:45 pmRNSAnnual General Meeting Update
24th Mar 20202:20 pmRNSDirector Declaration
16th Mar 20203:40 pmRNS2019 Annual Report & Accounts and Notice of AGM
13th Mar 202011:05 amRNSDirector/PDMR Shareholding
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
11th Mar 20203:45 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSPreliminary Results
27th Feb 202011:00 amRNSNon-Executive Director appointment
10th Jan 202012:45 pmRNSDirector/PDMR Shareholding
7th Nov 20192:00 pmRNSUpdate Statement following AGM Voting Outcome
1st Nov 201911:30 amRNSTotal Voting Rights
30th Oct 20197:00 amRNSQ3 Trading Update
21st Oct 20194:50 pmRNSDirector/PDMR Shareholding
21st Oct 20193:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.